SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-159696
Filing Date
2022-05-25
Accepted
2022-05-25 16:09:09
Documents
18
Period of Report
2022-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d535079d8k.htm   iXBRL 8-K 31546
2 EX-1.1 d535079dex11.htm EX-1.1 193891
3 EX-4.1 d535079dex41.htm EX-4.1 62360
4 EX-5.1 d535079dex51.htm EX-5.1 15499
5 EX-99.1 d535079dex991.htm EX-99.1 8524
9 GRAPHIC g535079g0524093930449.jpg GRAPHIC 4075
10 GRAPHIC g535079snap11.jpg GRAPHIC 13279
  Complete submission text file 0001193125-22-159696.txt   541754

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kdny-20220524.xsd EX-101.SCH 2864
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20220524_lab.xml EX-101.LAB 17996
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20220524_pre.xml EX-101.PRE 11267
12 EXTRACTED XBRL INSTANCE DOCUMENT d535079d8k_htm.xml XML 3361
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 22962961
SIC: 2834 Pharmaceutical Preparations